My HPRA: Register

Oruvail 2.5% w/w gel and Orugesic 2.5% w/w gel (ketoprofen) - Important Safety Information from Sanofi-Aventis as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 14/02/2011

  

Problem Or Issue:
Important Safety Information from Sanofi-Aventis on risk minimisation measures for ketoprofen-containing topical formulations

Important Safety Information - Oruvail 2.5% w/w gel and Orugesic 2.5% w/w gel (ketoprofen)

« Back